Publication:
Molecular Docking Studies of Glycyrrhetinic Acid Derivatives as Anti-Colorectal Cancer Agents
Molecular Docking Studies of Glycyrrhetinic Acid Derivatives as Anti-Colorectal Cancer Agents
No Thumbnail Available
Files
Date
2021
Authors
Nam Q.H. Doan
Tuyen N. Truong
Phuong T.V. Nguyen
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Abstract
In this study, the anti-CRC activities of 40 glycyrrhetinic acid derivatives were proposed
and evaluated by the molecular docking method, which allowed the flexibility of both ligand-receptor,
with twelve CRC-related targets. The proposed derivatives, which clearly distinguish isomers at
position 18 as well as the different tautomers, were divided into five groups including (1)
glycyrrhetinic acid and its oxidation derivatives, (2) glycoside derivatives, (3) 3β-amine derivatives,
(4) five-membered heterocyclic ring-combined derivatives, and (5) six-membered heterocyclic ringcombined
derivatives. Finally, we selected four out of twelve proposed targets related to CRC with
good binding affinities to the proposed glycyrrhetinic acid derivatives including Epidermal Growth
Factor Receptor (EGFR), Focal Adhesion Kinase (FAK), Lactate Dehydrogenase A (LDHA), and
Thymidylate Synthase (TS). From there, we also gained 9/40 derivatives for EGFR (pKd ≥ 9); 10/40
derivatives for FAK (pKd ≥ 10); 9/40 derivatives for LDHA (pKd ≥ 10), and 6/40 derivatives for TS
(pKd ≥ 9). The glycoside derivatives showed the best binding affinity (especially the glucuronide
derivative 5b), followed by the 3β-amino derivatives (especially the 3β-(phenylamino) derivative 8b)
and the five-membered heterocyclic ring-combined derivatives (especially the pyrrole derivative 10a
or pyrazole derivative 11.2a), while the six-membered heterocyclic ring-combined derivatives had
less potential to inhibit selected targets.
Description
Keywords
Molecular docking,
colorectal cancer,
glycyrrhetinic acid,
heterocyclic ring,
Surflex-Dock